alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANESOXLEY ACT OF 2002 In connection with the Quarterly Report of Cooper Industries, Ltd. (the
Company) on Form 10-Q for the period ended June 30, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, H.
John Riley, Jr., Chairman, President and Chief Executive Officer of the
Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of
the Sarbanes-Oxley Act of 2002, that to my knowledge:  (1)
    
    The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations
of the Company. /s/ H. John Riley, Jr.  
 August 4, 2004
IIB 

115TH CONGRESS 

2D SESSION H. R. 506 

IN THE SENATE OF THE UNITED STATES 

MARCH 15, 2018 

Received; read twice and referred to the Committee on the Judiciary 

AN ACT 

To amend title 18, United States Code, to provide an additional tool to prevent certain frauds against veterans, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


sradovich on DSK3GMQ082PROD with BILLS
2 

HR 506 RFS 

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Preventing Crimes 

3 Against Veterans Act of 2017’’. 

4 SEC. 2. ADDITIONAL TOOL TO PREVENT CERTAIN FRAUDS 

5 AGAINST VETERANS. 

6 (a) IN GENERAL.—Chapter 63 of title 18, United 

7 States Code, is amended by adding at the end the fol8 lowing: 

9 ‘‘§ 1352. Fraud regarding veterans’ benefits 

10 ‘‘(a) Whoever knowingly executes, or attempts to exe11 cute, any scheme or artifice to defraud an individual of 

12 veterans’ benefits, or in connection with obtaining vet13 eran’s benefits for that individual, shall be fined under this 

14 title, imprisoned not more than 5 years, or both. 

15 ‘‘(b) In this section— 

16 ‘‘(1) the term ‘veteran’ has the meaning given 

17 that term in section 101 of title 38; and 

18 ‘‘(2) the term ‘veterans’ benefits’ means any 

19 benefit provided by Federal law for a veteran or a 

20 dependent or survivor of a veteran.’’. 

21 (b) CLERICAL AMENDMENT.—The table of sections 

22 at the beginning of chapter 63 of title 18, United States 


sradovich on DSK3GMQ082PROD with BILLS
3 

HR 506 RFS 

1 Code, is amended by adding at the end the following new 

2 item: 

‘‘1352. Fraud regarding veterans’ benefits.’’. 

Passed the House of Representatives March 14, 

2018. 

Attest: KAREN L. HAAS, 

Clerk. 


sradovich on DSK3GMQ082PROD with BILLS
**CERTIFICATION
        OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION
        1350**
 
 In
        connection with the Form 10-QSB of Health Discovery Corporation formerly
        Direct
        Wireless Communications Inc. for the Quarter ended June 30, 2005, as filed
        with
        the Securities and Exchange Commission on the date hereof (the “Report”), I,
        Robert S. Braswell IV, Chief Financial Officer of Health Discovery Corporation,
        hereby certify pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906
        of
        the Sarbanes-Oxley Act of 2002, that:
 
 1.
              The
                  Report fully complies with the requirements of section 13(a) or
                  15(d) of
                  the Securities Exchange Act of 1934; and
 2.
              The
                  information contained in the Report fairly presents, in all material
                  respects, the financial condition and results of operation of Health
                  Discovery Corporation.
 
 
 Date:
        August 15, 2005
 
 
 /s/
        Robert S. Braswell IV
 
 Robert
        S.
        Braswell IV
 Chief
        Financial Officer
[Federal Register Volume 89, Number 8 (Thursday, January 11, 2024)]
[Notices]
[Page 1928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00442]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health and 
Human Development; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Eunice Kennedy Shriver National Institute of 
Child Health and Human Development Special Emphasis Panel; Member 
Conflict: Biobehavioral and Behavioral Sciences Study Section.
    Date: March 12, 2024.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Eunice Kennedy Shriver 
National Institute of Child Health and Human Development, 6710B 
Rockledge Drive, Bethesda, MD 20817, (Virtual Meeting).
    Contact Person: Magnus A. Azuine, Ph.D., Scientific Review 
Branch Eunice Kennedy Shriver National Institute, of Child Health & 
Human Development, NIH 6710B Rockledge Drive, Room 2125C Bethesda, 
MD 20817, (301) 480-4645, <a href="/cdn-cgi/l/email-protection#dab7bbbdb4afa9f4bba0afb3b4bf9ab4b3b2f4bdb5ac"><span class="__cf_email__" data-cfemail="036e62646d76702d6279766a6d66436d6a6b2d646c75">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: January 8, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00442 Filed 1-10-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
##### 



CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 Share-Based Payment
 (-s- KMJ Corbin & Company LLP)/s/ KMJ  Corbin & Company LLP
## 1 

# yt, ~~ir% RHODE ISLAND DEPARTMENT OF ENVIRONMENTAL MANAGEMENT 235 Promenade Street, Providence, R102908-5767 TDD401-222-4462

5 September 2008 Mr. David B. Conroy, Chief of Programs Branch EPA-New

England, Region I One Congress Street, Suite I 100 Mail Code : CAB Boston, MA 02203-0001 Dear Mr . Conroy: The Office ofAir Resources (OAR) is hereby submitting the enclosed Air Pollution Control Regulation No.37, entitled "Rhode Island Low Emission Vehicle Program" as a revision to the Rhode Island State Implementation Plan. The regulation adopted the California new vehicle emission standards known as the California LEVII programand became effective on 22 December 2005. Through this action, Rhode Island replaced the federal Tier 2 emission standards for new vehicles with the California standards. Section 177 ofthe federal Clean Air Act allows states to adopt new vehicle emission standards that are identical to the California standards. Anotice ofpublic comment period and public hearing concerning Air Pollution Control Regulation No. 37 was published in the Providence Journal on 31 October 2005 and on 7 November 2005 a second notice was published clarifying the date. Ahearing was held on 30 November 2005. Responses to the comments received are contained in the hearing Decision included with this submission. The following support documents are included: 1 . Notice of Public Hearing, Mailing List, Affidavit of Publication for the hearing notice published on 27 October 2005, DEM rules and regulation fact sheet ; 2 . a copy ofthe hearing officer's Decision; and 3 . a copy of Air Pollution Control Regulation No. 37 modified 22 December 2005 in response to comments received.

% 30%post-consumer fiberThe transcript of the public hearing, which was held on 30 November 2005, is available

fromour office upon request . If you have any questions regarding this regulation submittal pleasePontact Frank Stevenson of my staff at (401) 222-2808 ext . 7021 . Sincerely, Stephen M~ut, Chief Office ofAC'i-r Resources Department of Environmental Management cc: enclosure
##### 



No. 2-33-14542
    
    Form S-8 Registration Statement for Cooper Industries, Inc.
1989 Employee Stock Purchase PlanNo. 333-02847
    
    Form S-8 Registration Statement for Cooper Industries, Inc.
Amended and Restated Directors Stock PlanNo. 333-120337
    
    Form S-8 Registration Statement for Cooper Industries, Inc.
Amended and Restated Stock Incentive PlanNo. 333-24237
    
    Form S-3D Registration Statement for Cooper Industries,
Inc. Dividend Reinvestment and Stock Purchase PlanNo. 333-101451
    
    Form S-3D Registration Statement for Cooper Industries,
Ltd. Dividend Reinvestment and Stock Purchase PlanNo. 333-51439
    
    Form S-8 Registration Statement for Cooper Industries, Inc.
Directors Retainer Fee Stock PlanNo. 333-51441
    
    Form S-8 Registration Statement for Cooper Industries, Inc.
Amended and Restated Management Annual Incentive PlanNo. 333-37580
    
    Form S-8 Registration Statement for Cooper (UK) Employee
Share Purchase Plan
<Page>

                                                                    EXHIBIT 31.2

I, Steven E. Shebik, certify that:

1. I have reviewed this report on Form 10-K of Lincoln Benefit Life Company;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.

Date: March 15, 2005

                                                       /s/ Steven E. Shebik
                                                       --------------------
                                                       Steven E. Shebik
                                                       Senior Vice President and
                                                       Chief Financial Officer
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

STANDFORD KODUAH, 

Petitioner, 

 v. 

JEFFERSON B. SESSIONS III, Attorney 

General, 

Respondent.

No. 16-70378 

Agency No. A208-308-095 

MEMORANDUM*

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted October 23, 2017**

Before: McKEOWN, WATFORD, and FRIEDLAND, Circuit Judges. 

Standford Koduah, a native and citizen of Ghana, petitions pro se for review 

of the Board of Immigration Appeals’ (“BIA”) order dismissing his appeal from an 

immigration judge’s decision denying his application for asylum, withholding of 

removal, and relief under the Convention Against Torture (“CAT”). We have 

 

* This disposition is not appropriate for publication and is not precedent 

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision 

without oral argument. See Fed. R. App. P. 34(a)(2).

FILED

OCT 27 2017

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 16-70378 

jurisdiction under 8 U.S.C. § 1252. We review for substantial evidence the 

agency’s factual findings, Silaya v. Mukasey, 524 F.3d 1066, 1070 (9th Cir. 2008), 

and we review de novo due process contentions, Cruz Rendon, 603 F.3d 1104, 

1109 (9th Cir. 2010). We deny the petition for review.

Substantial evidence supports the agency’s finding that Koduah’s failed to 

establish past persecution or a likelihood of future persecution by his cousin in 

Ghana on account of a protected ground. See Molina-Morales v. INS, 237 F.3d 

1048, 1051-52 (9th Cir. 2001) (personal dispute is not grounds for relief unless 

connected to a protected ground). Thus, we deny the petition as to Koduah’s 

asylum and withholding of removal claims.

Substantial evidence supports the agency’s denial of Koduah’s CAT claim 

because he failed to establish it is more likely than not he would be tortured by or 

with the consent or acquiescence of the government if returned to Ghana. See 

Silaya, 524 F.3d at 1073. 

We reject Koduah’s contention that the agency violated his due process 

rights. See Lata v. INS, 204 F.3d 1241, 1246 (9th Cir. 2000); Tawadrus v. 
3 16-70378 

Ashcroft, 364 F.3d 1099, 1103 (9th Cir. 2004) (requirements for knowing and 

voluntary waiver of the right to counsel). 

PETITION FOR REVIEW DENIED.
CERTIFICATION  PURSUANT  TO  SECTION  302  OF  THE  SARBANES-OXLEY  ACT  OF 2002

I,  James  P.  Stapleton,  certify  that:

1.  I  have  reviewed this Annual Report on Form 10-KSB of PeopleView, Inc. (the
"Registrant");

2.  Based  on  my  knowledge,  this  Annual  report  does not contain any untrue
statement  of a material fact or omit to state a material fact necessary to make
the  statements  made, in light of the circumstances under which such statements
were  made,  not  misleading  with  respect to the period covered by this Annual
Report;

3.  Based  on  my  knowledge,  the  financial  statements,  and  other financial
information  included  in  this  annual  report,  fairly present in all material
respects  the  financial  condition, results of operations and cash flows of the
registrant  as  of,  and  for,  the  periods  presented  in  this Annual Report;

4.  PeopleViews' other certifying officer and I are responsible for establishing
and  maintaining  disclosure controls and procedures (as defined in Exchange Act
Rules  13a-14)  for  the  registrant  and  have:
d)     designed  such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is  made  known  to  me by others within those entities, particularly during the
period  in  which  this  annual  report  is  being  prepared;
e)     evaluated  the  effectiveness of the registrant's disclosure controls and
procedures  as  of a date within 90 days prior to the filing date of this Annual
Report  (the  "Evaluation  Date");  and
f)     presented in this Annual Report my conclusions about the effectiveness of
the  disclosure  controls  and  procedures  based  on  my  evaluation  as of the
Evaluation  Date;

5.  I  have  disclosed,  based on my most recent evaluation, to the registrant's
auditors  and the audit committee of registrant's board of directors (or persons
performing  the  equivalent  functions):
c)     all  significant  deficiencies  in  the  design  or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and  have  identified for the
registrant's  auditors  any  material  weaknesses  in  internal  controls;  and
d)     any  fraud,  whether  or  not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6. I have indicated in this annual report whether there were significant changes
in  internal  controls  or  in  other  factors  that  could significantly affect
internal controls subsequent to the date of my most recent evaluation, including
any  corrective  actions  with  regard  to significant deficiencies and material
weaknesses.

Dated:  April  14,  2004


 /s/  James  P.  Stapleton
--------------------------
James  P.  Stapleton,
Chief  Financial  Officer
(Principal  Financial  Officer)
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the incorporation by reference in the Registration
Statements on Forms S-8 (File Nos. 333-62733 and 333-50910) and
on Forms S-3 (File Nos. 333-65536, 333-74172 and 333-96939) of
LifePoint, Inc. and in the related Prospectus of our report dated
June 27, 2003 (except Note 9, as to which the date is July 14,
2003), with respect to the financial statements of LifePoint, Inc.
included in this Annual Report (Form 10-K/A Amendment No. 2) for
the year ended March 31, 2003.


                      			ERNST & YOUNG LLP

Orange County, California
July 14, 2003
J-1 Visa Placement Verification Form Page 1 of 1

J-1 Placement Verification Form

Physician Name:_____________________________________________________________________________________ 

USCIS J-1 Visa Waiver Approval Date: _________________ H-1(b) Visa Approval Date: ________________ 

ARC Commitment Employment Start Date: _____________ (within 90 days of USCIS approval of ARC J-1 Visa 

Waiver request)

Home Address:

Street: ________________________________________________________________

City: ___________________________ State: ____________ Zip Code: __________

Phone: _____________________________________ Email: _____________________________________________

Type of Medical Practice: __________________________

Location of Medical Specialty: 

Street: _________________________________________________________

City: _______________________________State: ______________________

County: ________________________________________________________

HPSA: __________________________________________________________

Phone: _________________________ Email: _________________________

Additional locations (if applicable): 

________________________________________________________________________________________________________________

________________________________________________________________________________________________________________

________________________________________________________________________________________________________________

I HEREBY CERTIFY THAT I, THE UNDERSIGNED, DO PROVIDE PRIMARY HEALTH CARE SERVICES AT THE 

ABOVE STATED LOCATION(S) A MINIMUM OF 40 HOURS PER WEEK.

__________________________________________ ___________________________

Physician Signature Date

(Notary)

I HEREBY CERTIFY THAT DOCTOR __________________________________ PROVIDES A MINIMUM OF 40 HOURS 

PER WEEK OF PRIMARY HEALTH CARE IN THE ABOVE LISTED ARC HPSA LOCATION(S). 

___________________________ _______________ _________________________ _______________________

Sponsor Signature Date Phone Email

(Notary) 

___________________________

Printed Name

RETURN THIS FORM TO: 

Deann Reed Fairfax, J-1 Program Manager

dfairfax@arc.gov

SEND COPY TO ARC J-1 CONTACT IN REQUESTED STATE

List available at www.arc.gov
```

[Congressional Record Volume 158, Number 124 (Friday, September 14, 2012)]
[House]
[Page H6003]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                 DESIGNATION OF THE SPEAKER PRO TEMPORE

  The SPEAKER pro tempore laid before the House the following 
communication from the Speaker:

                                               Washington, DC,

                                               September 14, 2012.
       I hereby appoint the Honorable Rob Bishop to act as Speaker 
     pro tempore on this day.
                                                  John A. Boehner,
     Speaker of the House of Representatives.

                          ____________________
```